摘要
目的:探索中西医结合治疗慢性乙型肝炎肝纤维化及早期肝硬化的效果。方法:选取2017年4月22日-2018年4月22日期间我院慢性乙型肝炎肝纤维化及早期肝硬化100例患者(实施奇偶数法分组模式),对照组的50例患者进行常规西医治疗,观察组的50例患者进行中西医结合治疗。结果:观察组患者的脾厚度(3.14±0.51)cm、脾静脉(0.42±0.13)cm、门静脉(1.03±0.06)cm、Ⅳ型胶原(Collage TypeⅣ,Ⅳ-C)(71.62±8.53)μg/L、层粘连蛋白(Laminin,LN)(114.19±24.19)μg/L、透明质酸(hyaluronidase,HA)(125.95±24.27)μg/L、白蛋白(Albumin,ALB)(41.85±5.19)g/L、血清总胆红素(Total Bilirubin,TBIL)(24.39±2.34)μmol/L、丙氨酸转氨酶(Alanine Aminotransferase,ALT)(25.16±3.22)U/L、总有效率(96.00%)均优于对照组(P<0.05)。结论:对慢性乙型肝炎肝纤维化及早期肝硬化患者实施中西医结合治疗效果明显。
Objective:To investigate the efficacy of the integrative medicine on chronic hepatitis B liver fibrosis and early cirrhosis.Methods:From April 22,2017 to April 22,2018,100 cases were divided into two groups,50 cases in each.The control group was given conventional western medicine;and the observation group was given the integrative medicine.Results:In the observation group,the spleen thickness was(3.14±0.51)cm,the splenic vein was(0.42±0.13)cm,the portal vein was(1.03±0.06)cm,IV-C was(71.62±8.53)μg/L,and LN was(114.19±24.19)μg/L,HA was(125.95±24.27)μg/L,ALB was(41.85±5.19)g/L,TBIL was(24.39±2.34)μmol/L,ALT was(25.16±3.22)U/L,and the total efficiency was 96.00%,were better than those in the control group(P<0.05).Conclusion:The integrative medicine on chronic hepatitis B liver fibrosis and early cirrhosis shows good effects.
出处
《中医临床研究》
2019年第28期4-6,共3页
Clinical Journal Of Chinese Medicine
关键词
中西医结合
慢性乙型肝炎
肝纤维化
早期肝硬化
The integrative medicine
Chronic hepatitis B
Liver fibrosis
Early cirrhosis
